These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2574975)

  • 1. Protein kinase C and dopamine release--III. Effect of dopamine depleting drugs.
    Giambalvo CT
    Biochem Pharmacol; 1989 Dec; 38(24):4445-54. PubMed ID: 2574975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C and dopamine release--II. Effect of dopamine acting drugs in vivo.
    Giambalvo CT
    Biochem Pharmacol; 1988 Oct; 37(20):4009-17. PubMed ID: 3056415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR; Eliassi A
    Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of D-1 and D-2 receptors in apomorphine-induced pecking in chicks.
    Zarrindast MR; Amin R
    Psychopharmacology (Berl); 1992; 106(1):67-70. PubMed ID: 1346722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT; Wagner RL
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic effect of locally applied apomorphine and 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine on the release of striatal dopamine investigated by means of brain dialysis.
    Kurata K; Shibata R
    Neurosci Lett; 1990 Sep; 117(3):264-8. PubMed ID: 1982738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study.
    Yang CR; Mogenson GJ
    Brain Res; 1990 Aug; 524(2):271-81. PubMed ID: 1981327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenoldopam on alpha-methyl-p-tyrosine-stimulated prolactin secretion in conscious rats.
    Schoors DF; Dupont AG
    Eur J Pharmacol; 1989 Nov; 173(1):109-12. PubMed ID: 2575038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT
    Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C and dopamine transport--1. Effects of amphetamine in vivo.
    Giambalvo CT
    Neuropharmacology; 1992 Dec; 31(12):1201-10. PubMed ID: 1361665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasting effects of dopamine receptor agonists upon striatal dopamine release in free-moving rats: an in vivo voltammetric study.
    Abraini JH; Fechtali T; Rostain JC
    Brain Res; 1994 Apr; 642(1-2):199-205. PubMed ID: 8032880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.